ACCESS TO THE INFORMATION AND DOCUMENTS ON THIS PORTION OF THE WEBSITE IS RESTRICTED FOR REGULATORY REASONS. YOU ARE REQUESTED TO REVIEW THE FOLLOWING INFORMATION AND MAKE THE FOLLOWING CONFIRMATION EACH TIME YOU SEEK TO ACCESS THIS RESTRICTED INFORMATION. PLEASE READ THIS NOTICE CAREFULLY – IT APPLIES TO ALL PERSONS WHO VIEW THIS PORTION OF THE WEBPAGE. PLEASE NOTE THAT THE DISCLAIMER SET OUT BELOW MUST NOT BE ALTERED OR UPDATED. YOU SHOULD READ IT IN FULL EACH TIME YOU VISIT THIS WEBSITE, AND YOUR CONFIRMATION MUST BE TRUE AND ACCURATE.

The materials contained in this section of this website (a) are only intended for, and may only be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident and physically present outside the United States of America (including its territories and possessions, any state of the United States and the District of Columbia, the "United States"), Canada, Australia, South Africa, New Zealand, Hong Kong or Japan, and resident and physically present in a jurisdiction where to do so will not constitute a violation of the local securities laws or regulations of such jurisdiction, and (b) do not constitute an offer to sell or the solicitation of an offer to buy or acquire any securities of the Company in the United States of America, Canada, South Africa, New Zealand, Australia, Hong Kong, Japan, or any other jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

The shares of BerGenBio ASA (the "Company") referred to in this section of the website (the "Shares") have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any state of the United States for offer or sale as part of their distribution and may not be offered or sold within the United States. Furthermore, the Shares have not been and will not be registered under the applicable securities laws of Canada, Australia, South Africa, New Zealand, Hong Kong, Japan, or any other jurisdiction in which it would be unlawful or would require registration or other measures, and therefore may not be offered or sold to or for the account or benefit of any person having a registered address in, or located or resident in, Canada, Australia, South Africa, New Zealand, Hong Kong, Japan or any other jurisdiction in which it would be unlawful or would require registration or other measures.

Any investment or investment activity to which this information relates is available only to, and will be engaged in only with, persons who (i) are outside the United Kingdom, (ii) are investment professionals falling within Article 19(5) of the U.K. Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth companies, and other persons to whom it may lawfully be engaged with, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "relevant persons"). The Shares are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such Shares will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on these documents or any of their contents.

THE INFORMATION AND DOCUMENTS ON THIS PORTION OF THE WEBSITE DO NOT CONSTITUTE A PROSPECTUS FOR THE PURPOSES OF REGULATION (EU) 2017/1129 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL OF 14 JUNE 2017 (SUCH REGULATION, TOGETHER WITH ANY AMENDMENTS THERETO AND ANY APPLICABLE IMPLEMENTING MEASURES IN THE RELEVANT HOME MEMBER STATE UNDER SUCH REGULATION, THE "EU PROSPECTUS REGULATION").

In any EEA Member State that has implemented the EU Prospectus Regulation, the information and documents on this portion of the website are only addressed to and are only directed at qualified investors in that Member State within the meaning of the EU Prospectus Regulation.

Access to the information contained on this portion of the website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons who wish to have access to the documents contained in this section of the website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this section of the website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been or will be obtained. Neither the Company nor the Managers (or any of their affiliates) assumes any responsibility if there is a violation of applicable law and regulations by any person.

To confirm that you (a) have read, understand and agree to comply with all of the restrictions set forth above and that your country of residence and current location is not the United States, Australia, Canada, South Africa, New Zealand, Hong Kong or Japan or any other jurisdiction in which such a distribution or such access is unlawful, and (b) are permitted to proceed to electronic versions of the information and documents on this portion of the websites, please select "YES" below:

Viktig informasjon knyttet til frittstående tegningsretter (Warrants) utstedt i forbindelse med fortrinnsrettsemisjonen i juni 2023

PLEASE CONFIRM YOUR LOCATION